UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Journal of clinical oncology, 2020-07, Vol.38 (21), p.2369-2379

2020

Volltextzugriff (PDF)

Advances in Small Cell Lung Cancer

Hematology/oncology clinics of North America, 2017-02, Vol.31 (1), p.143-156

2017

Volltextzugriff (PDF)

Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2017-05, Vol.35 (13), p.1395-1402

2017

Volltextzugriff (PDF)

High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients

Cancers, 2020-01, Vol.12 (1), p.127

2020

Volltextzugriff (PDF)

Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer

Scientific reports, 2022-05, Vol.12 (1), p.9054-9054, Article 9054

2022

Volltextzugriff (PDF)

Smoking status and survival in the national comprehensive cancer network non–small cell lung cancer cohort

Cancer, 2013-02, Vol.119 (4), p.847-853

2013

Volltextzugriff (PDF)

Treatment of Lung Cancer

The Radiologic clinics of North America, 2012-09, Vol.50 (5), p.961-974

2012

Volltextzugriff (PDF)

Small Cell Lung Cancer

Seminars in respiratory and critical care medicine, 2016-10, Vol.37 (5), p.783-796

Kalemkerian, Gregory P

2016

Volltextzugriff (PDF)

Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

Journal of clinical oncology, 2018-03, Vol.36 (9), p.911-919

2018

Volltextzugriff (PDF)

Eyelid metastasis in non-small-cell lung cancer: diagnosis and management

The American journal of medicine, 2016-09, Vol.129 (9), p.e169-e172

2016

Volltextzugriff (PDF)

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial

Nature medicine, 2022-08, Vol.28 (8), p.1640-1645

2022

Volltextzugriff (PDF)

Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

Chest, 2013-05, Vol.143 (5 Suppl), p.e400S-e419S

2013

Volltextzugriff (PDF)

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Journal of thoracic oncology, 2018-09, Vol.13 (9), p.1393-1399

2018

Volltextzugriff (PDF)

Advances in pharmacotherapy of small cell lung cancer

Expert opinion on pharmacotherapy, 2014-11, Vol.15 (16), p.2385-2396

Kalemkerian, Gregory P

2014

Volltextzugriff (PDF)

Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma: Final Report of a Phase II Trial

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3567-3572

2008

Volltextzugriff (PDF)

Combination chemotherapy for relapsed small-cell lung cancer

The lancet oncology, 2016-08, Vol.17 (8), p.1033-1035

Kalemkerian, Gregory P

2016

Volltextzugriff (PDF)

Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations

Journal of thoracic oncology, 2016-09, Vol.11 (9), p.1493-1502

2016

Volltextzugriff (PDF)

Notch Pathway Activity Identifies Cells with Cancer Stem Cell―like Properties and Correlates with Worse Survival in Lung Adenocarcinoma

Clinical cancer research, 2013-04, Vol.19 (8), p.1972-1980

2013

Volltextzugriff (PDF)

Reply to M.S. Copur et al

Journal of clinical oncology, 2018-07, Vol.36 (19), p.2007-2007

2018

Volltextzugriff (PDF)

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

JTO clinical and research reports, 2023-11, Vol.4 (11), p.100572-100572, Article 100572

2023

Volltextzugriff (PDF)

An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations

Expert opinion on pharmacotherapy, 2022-09, Vol.23 (14), p.1569-1575

2022

Volltextzugriff (PDF)

Cyclin-dependent kinase inhibitors for the treatment of lung cancer

Expert opinion on pharmacotherapy, 2020-05, Vol.21 (8), p.941-952

2020

Volltextzugriff (PDF)

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Journal of clinical oncology, 2023-12, Vol.41 (35), p.5448-5472

2023

Volltextzugriff (PDF)

Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels

Translational oncology, 2018-02, Vol.11 (1), p.102-108

2018

Volltextzugriff (PDF)

Staging and imaging of small cell lung cancer

Cancer imaging, 2012-01, Vol.11 (1), p.253-258

Kalemkerian, Gregory P

2012

Volltextzugriff (PDF)

1 – 25 von 166

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(127)

Publikationsform

Artikel
(165)
Buchkapitel
(1)

Sprache

Englisch
(166)

Erscheinungsjahr

n.n

Thema

Humans
(117)
Science & Technology
(113)
Life Sciences & Biomedicine
(112)
Oncology
(90)
Female
(58)
Male
(56)
Lung Neoplasms - Pathology
(54)
Aged
(50)
Middle Aged
(48)
Lung Neoplasms - Drug Therapy
(45)
Lung Cancer
(36)
Biological And Medical Sciences
(33)
Medical Sciences
(33)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Adult
(30)
Chemotherapy
(28)
Aged, 80 And Over
(25)
Carcinoma, Non-Small-Cell Lung - Pathology
(23)
Lung Neoplasms - Therapy
(21)
Respiratory System
(21)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study

Advances in Small Cell Lung Cancer

Cardiac Events After Radiation Therapy: Combined Analysis of Prospective Multicenter Trials for Locally Advanced Non-Small-Cell Lung Cancer

High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients

Cellular engagement and interaction in the tumor microenvironment predict non-response to PD-1/PD-L1 inhibitors in metastatic non-small cell lung cancer

Smoking status and survival in the national comprehensive cancer network non–small cell lung cancer cohort

Treatment of Lung Cancer

Small Cell Lung Cancer

Eyelid metastasis in non-small-cell lung cancer: diagnosis and management

Pan-cancer efficacy of pralsetinib in patients with RET fusion-positive solid tumors from the phase 1/2 ARROW trial

Treatment of small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

Phase II Study of Maintenance Pembrolizumab in Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)

Advances in pharmacotherapy of small cell lung cancer

Pemetrexed Plus Gemcitabine As First-Line Chemotherapy for Patients With Peritoneal Mesothelioma: Final Report of a Phase II Trial

Combination chemotherapy for relapsed small-cell lung cancer

Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations

Notch Pathway Activity Identifies Cells with Cancer Stem Cell―like Properties and Correlates with Worse Survival in Lung Adenocarcinoma

Reply to M.S. Copur et al

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

An evaluation of sotorasib for the treatment of patients with non-small cell lung cancer with KRASG12C mutations

Cyclin-dependent kinase inhibitors for the treatment of lung cancer

Systemic Therapy for Small-Cell Lung Cancer: ASCO-Ontario Health (Cancer Care Ontario) Guideline

Prediction of Radiation Esophagitis in Non–Small Cell Lung Cancer Using Clinical Factors, Dosimetric Parameters, and Pretreatment Cytokine Levels

Staging and imaging of small cell lung cancer

Suchergebnisse filtern